DaVinci Biosciences is dedicated to the discovery and development of biopharmaceuticals for the treatment of human degenerative disorders to provide significant advantages over standard of care treatments. The Company's primary areas of focus are cell-based therapeutics and the use of small molecule compounds to treat neurodegenerative disorders such as spinal cord injury and amyotrophic lateral sclerosis.
